Artigo
Revisado por pares
Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome
2007; Springer Science+Business Media; Volume: 52; Issue: 3 Linguagem: Inglês
10.1007/s10620-006-9312-0
ISSN1573-2568
AutoresEric Esrailian, Eugene R. Pantangco, Namgyal L. Kyulo, Ke‐Qin Hu, Bruce A. Runyon,
Tópico(s)Renal function and acid-base balance
Referência(s)